Sight Sciences Inc. (SGHT): Kapitalizatsiyaning daromadga nisbati

Sight Sciences Inc. (SGHT) brendining ramzi va logotipi

Sight Sciences, Inc. (SGHT) plastikdan foydalanishni kamaytirish orqali oftalmologik uskunalar ishlab chiqarishda ekologik toza standartlarni joriy qilmoqda. Narx-sotuvlar nisbati ushbu jarayonning dinamikasini vizuallashtiradi, bunda 6.80 darajasi parametrning holatini ko'rsatadi. Barqaror talab uning mikroxirurgik asboblarining noyob ergonomikasi bilan ta'minlanmoqda. Shu bilan birga, Sight Sciences, Inc. (SGHT) shifokorlarni yangi metodologiyalarga tizimli ravishda o'qitish orqali glaucoma davolash segmentidagi tartibga soluvchi o'zgarishlar risklarini yumshatmoqda.

SGHT Sight Sciences Inc. P/S multiplikatori (04.07.2022 - 14.11.2026)

Sight Sciences, Inc (SGHT) kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi sightsciences.com|SGHT - Maqsadli narxlar grafigi
- birja kapitallashuvi ma'lumotlari:
Bozor bahosi Sight Sciences, Inc|SGHT - Korxona qiymati
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga sof aktivlar qiymati Sight Sciences, Inc.|SGHT - Balans kapitallashuvi|Kapitallashuvning balans qiymatiga nisbati sightsciences.com|SGHT - Kompaniyaning umumiy aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Sight Sciences, Inc.|SGHT - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Sight Sciences Inc|SGHT - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Sight Sciences, Inc|SGHT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Sight Sciences, Inc.|Oraliq qoplash koeffitsiyenti sightsciences.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
SGHT - Sof foyda|Kutilayotgan sof foyda Sight Sciences, Inc.|SGHT - Narxning foydaga nisbati|Forvard narx-foyda multiplikatori Sight Sciences Inc.|SGHT - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Sight Sciences, Inc|SGHT - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Sight Sciences, Inc.|SGHT - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi sightsciences.com|SGHT - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Sight Sciences, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
SGHT - Daromad va sotish hajmi|Kompaniyaning kutilayotgan sotish hajmi sightsciences.com|SGHT - Narxning daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati Sight Sciences, Inc
Kompaniyaning umumiy tahlili:SGHT sightsciences.com
Sight Sciences, Inc. asosiy tovari

Barqaror aktivlarning professional tanlovi aktiv uchun haddan tashqari ko'p to'lov qilishdan qochish uchun biznesning bozor qiymatini haqiqiy savdo hajmi bilan muvofiqlashtirishni talab qiladi. Narx/savdo koeffitsiyentini tahlil qilish orqali investor bozor kapitalizatsiyasining yillik daromadga nisbatini baholaydi, bu Sight Sciences, Inc. (SGHT) uchun ayniqsa muhimdir, chunki yuqori R&D xarajatlari va OMNI tizimlarining ishlab chiqilishi ushbu metrikan innovatsiyalarni tijoratlashtirish samaradorligining asosiy ko'rsatkichi qiladi.

Sight Sciences, Inc. raqobatchilari

BSX (bostonscientific.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Edwards Lifesciences Corporation EW|RMD - Kapitalizatsiyaning daromadga nisbati|OmniPod - P/S multiplikatori|Sotuvga nisbatan narx Zimmer Biomet Holdings|COO: P/S multiplikatori|Kapitalizatsiya va daromad nisbati ALGN|GMED (Globus Medical) - P/S multiplikatori|TransMedics Group Inc (TMDX) - Narx/daromad koeffitsiyenti|P/S multiplikatori ATEC|Kapitalizatsiyaning daromadga nisbati Artivion Corp AORT|P/S multiplikatori ENOV (Enovis Corporation)|P/S multiplikatori integralife.com IART|ESTA - Narxning daromadga nisbati|BBNX: Narxning daromadga nisbati|IRMD (Iradimed) - Kapitalizatsiyaning daromadga nisbati|Embecta Health - Bozor kapitallashuvining daromadga nisbati|TNDM (Tandem Diabetes Care) - P/S multiplikatori|Sotuvga nisbatan narx axogeninc.com AXGN|Narxning daromadga nisbati SI-BONE (SIBN)|Orthofix Medical (OFIX) - Narx/daromad multiplikatori|Bioventus Corp - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori OrthoPediatrics Corp KIDS|Treace Medical Concepts - P/S multiplikatori|Narx/daromad koeffitsiyenti blade.com SRTA|Carlsmed (CARL) - Narxning daromadga nisbati|Narxning sotuvga nisbati RXST (RxSight Inc)|Narxning daromadga nisbati ClearPoint Neuro Inc.|Kapitalizatsiyaning daromadga nisbati Stereotaxis Corporation (STXS)|P/S multiplikatori STIM|OBIO - Sotuvga nisbatan narx|Narxning daromadga nisbati Anika Therapeutics, Inc. ANIK|NSPR: Kapitalizatsiya va daromad nisbati|ZJYL: Kapitalizatsiyaning daromadga nisbati|Vivani Medical, Inc. - Kapitalizatsiyaning sotish hajmiga nisbati|xtantmedical.com (XTNT) - Narxning daromadga nisbati|NMTC - Narx/daromad koeffitsiyenti|MODD (Modular Medical Inc) - P/S multiplikatori|Myomo Inc. (MYO) - Narx/daromad koeffitsiyenti|P/S multiplikatori COCH|Vivos Therapeutics Inc (VVOS) - Narx/daromad multiplikatori|P/S multiplikatori NVNO (enVVeno Medical)|Bozor kapitallashuvining daromadga nisbati SINT|TNON: Kapitalizatsiyaning daromadga nisbati|ReWalk Robotics - Kapitalizatsiyaning sotish hajmiga nisbati|AMIX (autonomix.com) - Kapitalizatsiyaning daromadga nisbati|INVO Fertility Corp - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Bone Biologics|axonics.com (AXNX) - Narx/daromad koeffitsiyenti|P/S multiplikatori BIOL|Kapitalizatsiyaning daromadga nisbati dynatronics.com DYNT|P/S multiplikatori FNA (Paragon 28)|Narx/daromad koeffitsiyenti INVO Bioscience Inc. (INVO)